↓ Skip to main content

SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane…

Overview of attention for article published in Trials, August 2021
Altmetric Badge

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Published in
Trials, August 2021
DOI 10.1186/s13063-021-05461-9
Pubmed ID
Authors

Sarah Halford, Susan Wan, Ilaria Dragoni, Julie Silvester, Bobojon Nazarov, Daniel Anthony, Suzie Anthony, Emma Ladds, John Norrie, Kevin Dhaliwal

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 9%
Researcher 5 7%
Student > Master 4 6%
Librarian 3 4%
Student > Ph. D. Student 3 4%
Other 6 9%
Unknown 40 60%
Readers by discipline Count As %
Medicine and Dentistry 14 21%
Economics, Econometrics and Finance 2 3%
Social Sciences 2 3%
Agricultural and Biological Sciences 2 3%
Nursing and Health Professions 1 1%
Other 6 9%
Unknown 40 60%